BIIB059 Safe and Effective in Reducing CLE Activity Regardless of SLE
The efficacy of BIIBO59 in patients with cutaneous lupus erythematosus with and without concomitant systemic lupus erythematosus during 16 weeks was evaluated.
AAD 2021
Hidradenitis Suppurativa Associated With Increased Stroke Risk
The association between HS and strokes was assessed via a systematic review and meta-analysis.
Ruxolitinib Cream a Promising Option for Long-Term Vitiligo Treatment
The safety and efficacy of ruxolitinib cream following 104 weeks of treatment in a phase 2 study of adults is reported.
Complete Skin Clearance and Improved Joint Symptoms With Guselkumab in Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
IL-13 Cytokine Inhibitor Tralokinumab Shows Long-Term Durable Efficacy in Adult Atopic Dermatitis
Determining if treatment with tralokinumab would lead to long-term improvements in symptoms related to atopic dermatitis was the goal of this study.
Repeated Use of DaxibotulinumtoxinA for Injection Improved Glabellar Lines
The effect of repeated DAXI treatment on static glabellar line severity was evaluated.
Do Patients With Vitiligo Have Higher Risk for Metabolic Disturbances?
The prevalence and association of metabolic syndrome in patients with vitiligo was determined via analyses in this study.
Ligelizumab Improves Sleep in Patients With Chronic Spontaneous Urticaria
The effect of ligelizumab on sleep in patients with chronic spontaneous urticaria who had been treated with omalizumab is explored.
Trial Results Demonstrate Baricitinib’s Efficacy, Long-Term Safety for Atopic Dermatitis
Analyses demonstrated improvement in key treatment outcomes vs placebo associated with baricitinib for the treatment of atopic dermatitis.
Baricitinib Shows Therapeutic Potential in Early- to Late-Onset Alopecia Areata
Baseline characteristics and treatment outcomes of patients with early-onset and late-onset alopecia areata are evaluated.
Acne Treatment Inversely Linked to Positive Depression Screen in Adolescents, Young Adults
Researchers assessed the effects of BMI on topical acne treatments in younger patients.
Secukinumab for Nail and Axial Symptoms of Psoriatic Arthritis
The investigators reported efficacy results from the MAXIMISE trial, the first randomized controlled trial evaluating the efficacy of a biologic agent in the treatment of axial manifestations in PsA.
Methotrexate Therapy in Psoriasis Increases Nonmelanoma Skin Cancer Risk
A study shows 7.8% of patients with psoriasis who were treated with methotrexate developed nonmelanoma skin cancer.
Risankizumab Most Effective Long-Term Therapy for the Treatment of Plaque Psoriasis
The comparative efficacy of biologic agents and oral therapies for plaque psoriasis was evaluated.
Upadacitinib, Abrocitinib, and Dupilumab Show Highest Efficacy Among Systemic Therapies for AD
The efficacy and safety of systemic treatments for moderate to severe atopic dermatitis in monotherapy and combination therapy was investigated.
1% Tirbanibulin Ointment Proves Effective for Actinic Keratosis Lesions
Pooled data analyses on efficacy, safety, and 1-year follow-up on the use of tirbanibulin for the treatment of actinic keratosis lesions was presented at the AAD VMX 2021.
Sofpironium Bromide Gel a Treatment Option for Primary Axillary Hyperhidrosis
The safety, tolerability, and efficacy of sofpironium bromide gel for the treatment of primary axillary hyperhidrosis was evaluated.
89% Vichy Volcanic Mineralizing Water, Hyaluronic Acid Mixture Improve Signs and Symptoms of Rosacea
The influence of Vichy volcanic mineralizing water and hyaluronic acid treatment on rosacea was presented at the American Academy of Dermatology’s Virtual Meeting Experience (AAD VMX) 2021.
Roflumilast Foam is Safe, Offers Long-Term Efficacy for Psoriasis and Seborrheic Dermatitis
The latest data on the safety and efficacy of roflumilast foam for scalp and body psoriasis was presented at the American Academy of Dermatology’s Virtual Meeting Experience (AAD VMX) 2021.
Acne Treatment Efficacy Does Not Appear to Be Affected by BMI
The efficacy of topical acne treatments is not affected by body mass index (BMI).
Deucravacitinib Superior to Placebo, Apremilast in Moderate to Severe Plaque Psoriasis
Researchers compared the safety and efficacy of treatment with deucravacitinib vs placebo and apremilast in patients with moderate to severe plaque psoriasis.
Dupilumab and Topical Corticosteroids Offer Significant Improvement in AD Signs, Symptoms, and Quality of Life
Researchers sought to determine whether there were any clinically meaningful improvements in AD signs, symptoms, and quality of life in pediatric patients treated with different doses of dupilumab.
Possible Link Between High Risk SCC Tumors and Statins in Men
Study researchers presented their findings at AAD 2021 on the relationship between statin therapy and risk for squamous cell carcinoma tumors in men.
Ruxolitinib Cream Safe, Effective Atopic Dermatitis Treatment for Adolescents and Adults
Researchers at the AAD vmx 2021 describe the efficacy of ruxolitinib cream for atopic dermatitis based on baseline clinical characteristics using data from 2 studies.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AAD 2021
Loading... 
Loading...